The Effect of Honey-sweetened Coffee, Black Tea and Green Tea on Some Physiological Parameters

NCT07002307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-06-15

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate whether a three-day consumption of honey-sweetened black tea, green tea, and coffee will have an effect on blood pressure, heart rate, and blood glucose. The main questions it aims to answer are:

Does honey-sweetened black tea, green tea, and coffee, respectively, have the ability to influence blood pressure, heart rate, or blood glucose level?

Research will compare honey-sweetened black tea, green tea, and coffee to a placebo (warm water) to see if honey-sweetened black tea, green tea, and coffee work to reduce or increase blood pressure, heart rate, or blood glucose.

Participants will:

Take honey-sweetened black tea, green tea, and coffee, OR plain black tea, green tea, and coffee, OR warm water, one cup a day for 3 days The beverages will be taken at the Physiology laboratory, University of Uyo, and the participants will be observed for 60 minutes, during which their blood pressure, heart rate, and blood glucose level will be measured. This procedure will be repeated for the 3 days of study.

Conditions

  • Blood Pressure
  • Heart Rate
  • Blood Glucose

Interventions

OTHER

Warm water at 35 oC

The placebo for the control group

OTHER

Coffee

Instant coffee, Nescafé Gold Blend, manufactured by Nestlé Coffee Brand, Nestlé Global

OTHER

Honey-sweetened coffee

Instant coffee plus raw dark amber honey produced by Apis mellifera adansonii

OTHER

Green tea

Qualitea Natural Green Tea, packed by Qualitea Ceylon (PVT) LTD

OTHER

Honey-sweetened green tea

Green tea plus honey

OTHER

Black tea

Lipton Yellow Label Black Tea

OTHER

Honey-sweetened black tea

Black tea plus honey

Sponsors & Collaborators

  • University of Uyo Teaching Hospital

    lead OTHER

Principal Investigators

  • Esther O Aluko · University of Uyo

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2023-10-19
Completion
2023-10-19

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07002307 on ClinicalTrials.gov